Enfusion Inc’s recently made public that its Chief People Officer Bastone Bronwen unloaded Company’s shares for reported $35558.0 on Mar 05 ’25. In the deal valued at $11.38 per share,3,126 shares were sold. As a result of this transaction, Bastone Bronwen now holds 221,875 shares worth roughly $2.46 million.
Then, Campobasso Matthew sold 1,695 shares, generating $19,281 in total proceeds. Upon selling the shares at $11.38, the General Counsel now owns 70,946 shares.
Before that, Movchan Oleg sold 11,452 shares. Enfusion Inc shares valued at $130,473 were divested by the Chief Executive Officer at a price of $11.39 per share. As a result of the transaction, Movchan Oleg now holds 631,847 shares, worth roughly $7.01 million.
A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in late February from “a Neutral” to “a Sell”. JP Morgan also remained covering ENFN and has decreased its forecast on January 30, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. UBS started covering the stock on November 07, 2023. It rated ENFN as “a Neutral”.
Price Performance Review of ENFN
On Tuesday, Enfusion Inc [NYSE:ENFN] saw its stock jump 0.18% to $11.09. Over the last five days, the stock has lost -0.36%. Enfusion Inc shares have risen nearly 7.67% since the year began. Nevertheless, the stocks have risen 19.76% over the past one year. While a 52-week high of $11.80 was reached on 02/20/25, a 52-week low of $7.83 was recorded on 01/02/25. SMA at 50 days reached $11.07, while 200 days put it at $9.58.
Levels Of Support And Resistance For ENFN Stock
The 24-hour chart illustrates a support level at 11.04, which if violated will result in even more drops to 10.99. On the upside, there is a resistance level at 11.12. A further resistance level may holdings at 11.15. The Relative Strength Index (RSI) on the 14-day chart is 46.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.67%. Stochastics %K at 12.06% indicates the stock is a buying.
How much short interest is there in Enfusion Inc?
A steep rise in short interest was recorded in Enfusion Inc stocks on 2025-02-28, dropping by 62377.0 shares to a total of 0.95 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 1.01 million shares. There was a decline of -6.58%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 03, 2023 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $11 price target.
